BSG and obesity due to melanocortin 4 receptor deficiency: Nonetheless, BSG is up-regulated in a range of diseases, including those comorbidities or morbidities associated with increased risk for severe COVID-19 disease and poorer outcomes including thrombosis (47), pulmonary hypertension (48), renal disease (49), obesity (12), and diabetes (50).